Anna Säll is a Principal Scientist in Translational DMPK at H. Lundbeck A/S, specializing in antibody drug development with nine years of experience in the biotech industry. They have a strong background in project management, having successfully led complex antibody discovery projects that contributed to the advancement of therapeutic antibody candidates into clinical phase I development. Prior to their current role, Anna held positions as Director of Antibody Discovery at Alligator Bioscience AB and Research Engineer at the Department of Immunotechnology, Lund University. Anna earned both a Master of Science in Biotechnology and a PhD in Immunotechnology from Lunds tekniska högskola.
This person is not in any teams
This person is not in any offices